RxDoctor Payments Data

Eric Shah

Gastroenterology · Ann Arbor, MINPI 1487911376

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $108,460 of the $119,783 with a category attached, or 90.5%. 22 manufacturers reported payments, led by Neuraxis, Inc. at 26.4% of the total. 2025 is the largest year on record at $63,516, more than ten times the $204 reported in 2019. Among gastroenterology clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$119,783in general payments, 2019–2025

Across 64 payments — averaging $1871.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Neuraxis, Inc.$32K
  • Ardelyx, Inc.$28K
  • Takeda Pharmaceuticals U.S.A., Inc.$24K
  • Laborie Medical Technologies Corp.$7K
  • Regeneron$5K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$4K
  • plus $19K from 16 others
$2,360in research payments, 2019–2025

Across 1 payment — averaging $2360.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Neuraxis, Inc.$2K

What the payments were for

  • Consulting fees$108,46091%
  • Speaking & faculty fees$1,6491%
  • Travel & lodging$1,4551%
  • Food & beverage$2,4842%
  • Education$3,3753%
  • Charitable contribution$2,3602%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$119,783 in reported general payments places this provider in the 95th percentile of 497 gastroenterology providers in Michigan.

See all gastroenterology providers in Michigan

Medicare billing

Part B allowed, 2024
$51,716
Medicare patients
351
Services billed
623

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab14$101,659
Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg29$841

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Ann Arbor

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →